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Abstract;  14 
Study question: Is the developmental timing and metabolic regulation disrupted in 15 
embryos from overweight and obese women?  16 
Summary answer: Human oocytes from women presenting for fertility treatment 17 
with a body mass index (BMI) exceeding 25kg/m2 are smaller than those from 18 
women of healthy weight, yet post fertilization they reach the morula stage faster.  19 
Moreover, the blastocysts from overweight women show reduced glucose 20 
consumption and contain elevated levels of endogenous triglyceride. 21 
What is known already: Female overweight and obesity (OW/OB) is associated 22 
with infertility. Moreover, being overweight or obese around conception may have 23 
significant consequences for the unborn child, since there are widely acknowledged 24 
links between events occurring during early development and the incidence of a 25 
number of adult disorders.  26 
Study design, size, duration: We have performed a retrospective, observational 27 
analysis of oocyte size and the subsequent developmental kinetics of 218  oocytes 28 
from 29 consecutive women attending for ICSI treatment and related time to reach 29 
key developmental stages to maternal bodyweight.  In addition we have measured 30 
non-invasively the metabolic activity of 150  IVF/ ICSI embryos  from a further 29 31 
consecutive women who donated their surplus embryos to research, and related the 32 
data retrospectively to their BMI. 33 
Participants/materials, setting, methods: In a clinical IVF setting, we compared 34 
oocyte morphology and developmental kinetics of supernumerary embryos collected 35 
from overweight and obese women, with a body mass index (BMI) in excess of 36 
25kg/m2 to those from women of healthy weight. Full informed consent was obtained. 37 
A Primovision Time Lapse system was used to measure developmental kinetics and 38 
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the non-invasive COnsumption/RElese (CORE) of glucose, pyruvate, amino acids, 39 
and lactate were measured on spent droplets of culture medium.  Total triglyceride 40 
within individual embryos was also determined.   41 
Main results and the role of chance: Human oocytes from overweight women are 42 
smaller (R2 =-0.45; p=0.001) and less likely to complete development post-fertilization 43 
(p<0.001). Those embryos that do develop reach the morula stage faster than 44 
embryos from women of a BMI <25 kg/m2 (<0.001) and the resulting blastocyst 45 
contain fewer cells; notably in the trophectoderm (p=0.01).  The resulting blastocysts 46 
have reduced glucose consumption (R2=-0.61; p=0.001), modified amino acid 47 
metabolism and increased levels of endogenous triglyceride (t=4.11, p<0.001).  Our 48 
data further indicate that these differences are independent of male BMI. 49 
Limitations, reasons for caution: Although statistical power has been achieved, 50 
this is a retrospective study and relatively small due to the scarcity of human 51 
embryos available for research. Consequently, sub analysis of overweight and obese 52 
was not possible based on the sample size. The analysis has been performed on 53 
supernumerary embryos, originating from a single IVF unit and not selected for use 54 
in treatment. Thus it was not possible to speculate how representative the findings 55 
would be of the better quality embryos transferred or frozen for each patient.   56 
Wider implications of the findings: The data indicate that the BMI of women at 57 
conception is associated with distinct phenotypic changes in the embryo during the 58 
preimplantation period highlighting the importance of pre-pregnancy body weight in 59 
optimizing the chances of fertility and safeguarding maternal and offspring health. 60 
These changes to the metabolic fingerprint of human embryos are most likely a 61 
legacy of the ovarian conditions under which the oocyte has matured, may reduce 62 
the chances of conception for overweight women and provide good evidence that the 63 
metabolic profile of the early embryo is set by sub-optimal conditions around the time 64 
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of conception. The observed changes could indicate long-term implications for the 65 
health of the offspring of overweight and obese women  66 
Study funding/competing interest(s): Funded by the Hull IVF Unit Charitable Trust 67 
and the Hull York Medical School.   68 
Trial registration number: Not applicable. 69 
70 
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Introduction 71 
Rates of overweight and obesity are rising in women of reproductive age, in line with 72 
the global obesity epidemic.  Overweight and obesity, defined as a body mass index 73 
within the ranges 25-29.9kg/m2 and >30kg/m2 respectively, are reported to have a 74 
negative impact on female reproductive health, in terms of reduced conception rates, 75 
increased rate of miscarriage (Boots and Stephenson, 2011), and maternal, fetal and 76 
neonatal complications (Balen, et al., 2007).  In addition, being overweight during 77 
pregnancy increases the risk of developing gestational diabetes and large for 78 
gestational weight infants (Lawlor, et al., 2012); observations of particular importance 79 
given that weight at birth correlates with weight in later life (Rogers, et al., 2006).  80 
Epidemiological studies indicate that maternal body weight at conception and weight 81 
gain during the course of the pregnancy are associated with increased risk of 82 
cardiovascular and metabolic diseases in the offspring in later life (Lawlor, et al., 83 
2012, Reynolds, et al., 2013). While it is widely accepted that many adult disorders 84 
have their origins in early development (Gluckman and Hanson, 2004) it is 85 
increasingly apparent that maternal nutrition in the periconceptual period can affect 86 
oocyte quality (Machtinger, et al., 2012), embryo development and offspring health 87 
(Connor, et al., 2012).  88 
 89 
The ovarian follicle provides nutrients for the developing oocyte. For example, 90 
glucose present in the follicular cavity is principally converted to pyruvate by the 91 
granulosa-derived cumulus cells that surround the oocyte which is then transported 92 
into the oocyte where it is oxidised to provide ATP (Leese and Barton, 1984).  In 93 
addition, mammalian oocytes contain a significant endogenous triglyceride 94 
repository, (Sturmey, et al., 2009) which provides a source of metabolic energy 95 
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during oocyte maturation (Dunning, et al., 2010, Ferguson and Leese, 2006, Sturmey 96 
and Leese, 2003).   97 
 98 
The ovarian follicular environment is modified in obese women (Valckx, et al., 2012), 99 
with elevated levels of triglycerides, glucose and insulin (Robker, et al., 2009) the 100 
supply of which to the oocyte can have phenotypic consequences.  For example, the 101 
exposure of bovine oocytes to a high-fat environment during final maturation reduces 102 
embryo viability post fertilisation, changes the expression of key metabolic genes and 103 
modifies metabolic activity in the resulting blastocysts (Van Hoeck, et al., 2011).  104 
While the pattern of metabolism in human oocytes and preimplantation embryos has 105 
been studied in some detail (Brison, et al., 2004, Butcher, et al., 1998, Gardner, et 106 
al., 2011, Gott, et al., 1990, Hardy, et al., 1989, Houghton, et al., 2002, Martin, et al., 107 
1993, Sturmey, et al., 2009) little is known about whether the metabolic phenotype of 108 
the early embryo is sensitive to maternal body weight at the time of conception.  This 109 
may be important, since the metabolic profile of preimplantation embryos is linked to 110 
ongoing viability (Brison, et al., 2004, Gardner, et al., 2011).  Moreover, since critical 111 
epigenetic events occur during oogenesis (Kono, et al., 1996) and are completed 112 
postnatally (Lucifero, et al., 2004), a sub-optimal periconceptual environment may 113 
plausibly have a short- and/or long-term impact on development and set the early 114 
embryo on a metabolic trajectory that persists beyond the preimplantation period. 115 
This may increase the susceptibility of the offspring to the development of non-116 
communicable diseases, including cancer, (Walker and Ho, 2012) cardiovascular 117 
disease and diabetes, the aetiology of which are considered to have a developmental 118 
component (Hanson and Gluckman, 2011).   119 
 120 
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The aim of this study was therefore to discover whether embryos derived from 121 
oocytes of overweight and obese women display a compromised developmental and 122 
metabolic profile. In order to carry out this work, we were fortunate to receive human 123 
embryos conceived by In Vitro Fertilisation and donated for research purposes after 124 
clinical treatment had been completed, with full, informed ethical consent.   125 
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Methods;  126 
All research was carried out according to licence conditions of the Human 127 
Fertilisation and Embryology Authority (licence R0067), with full ethical approval 128 
(09/HI304/44).  129 
 130 
Female and male BMI were recorded at the down-regulation appointment and at the 131 
commencement of treatment to ensure that the patients were weight-stable (defined 132 
as maintaining weight over a period of three months). Embryos that originated from 133 
patients classified as OW/OB (BMI ≥25kg/m2) were compared to embryos derived 134 
from women of normal BMI (19 to 24.9kg/m2).  All patients indicating a willingness to 135 
be approached about research were given the opportunity to participate in the study. 136 
Only women with polycystic ovaries were excluded from the study as it was 137 
anticipated they might represent an additional subgroup with a specific metabolic 138 
profile linked with this condition. 139 
 140 
Ovarian stimulation and oocyte collection were performed as described (Dickerson, 141 
et al., 2010). There were no differences in the stimulation regimens administered to 142 
patients in this study, however the duration and starting dose was adjusted according 143 
to patient age, AMH and antral follicle count. The oocyte retrieval was scheduled 144 
once the second largest follicle had reached 18mm and all follicles above 15mm 145 
were drained. Oocytes were cultured at 370C in 6% CO2, 5% O2, in Sage Quinn’s 146 
Advantage (QA) Fertilisation Medium. Normally fertilised embryos were cultured until 147 
day 3 in QA Cleavage medium, and in QA Blastocyst medium until day 5 (all Sage 148 
QA products from Cooper Surgical, USA). Embryo transfer of one or two embryos 149 
was performed on day 3 or a single blastocyst on day 5, on the basis of the embryo 150 
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quality and surplus good quality blastocysts were cryopreserved for use in future 151 
treatment. Only then were patient consents checked and the remaining 152 
supernumerary developing embryos unsuitable for further clinical use donated to 153 
research, with full informed.  Figure 1 depicts a summary of patients, oocytes and 154 
embryos included in each analysis. Observations were continued until day 9 or 155 
developmental arrest, to permit data capture from slower developing embryos which 156 
continued to show viability.  157 
 158 
Oocyte assessments prior to ICSI and time-lapse development (observation 159 
and extended culture) 160 
Oocyte diameters were measured during routine treatment and audited to assess 161 
differences in the quality of mature oocytes attained from normal weight and OW/OB 162 
women. Prior to ICSI two perpendicular measurements were taken of the ooplasm of 163 
218 oocytes from 29 consecutive patients (see Figure 1A for details). As these 164 
measurements were taken prospectively, it was possible to track the onward 165 
developmental competence of the oocytes, based on their fertilisation, cleavage 166 
division to form embryos, development to form high scoring cleavage embryos, 167 
designated as having 6-8 cells on day 3 and a morphology score of grade 3 or 168 
above, and blastocyst formation on day 5. 169 
 170 
Post transfer (68-116 hours post insemination) there was a total of 101 surplus 171 
embryos at various stages of continuing development which were placed into 172 
extended culture and observed using time-lapse technology (Primovision). Embryos 173 
were cultured in WOW dishes (Primovision, supplied by Vitrolife, Sweden), in culture 174 
conditions as described above.  Recordings were made of specific developmental 175 
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timings/ events, using techniques described (Kirkegaard, et al., 2012). The time to 176 
reach 1) morula stage was defined as when all cells have fused, 2) unexpanded 177 
blastocyst; the first time a blastocyst is visible, 3) expanded blastocyst when the 178 
blastocoel expands 4) hatching; when the embryo escapes from the zona. The 179 
diameter of the blastocoel following collapse, recovery and hatching were also 180 
recorded.  181 
 182 
Research embryo culture, assessment and metabolic assays  183 
A second cohort of 29 consecutive patients presenting for IVF at the Hull IVF Unit 184 
donated a total of 150 embryos with full informed consent (See Figure 1C for details). 185 
Surplus embryos donated to research had their development stage recorded before 186 
being placed individually into 4µl drops of Earle’s balanced salt solution, 187 
supplemented with 1mM glucose, 0.47mM pyruvate, 5mM Lactate, a physiological 188 
mixture of amino acids (Houghton, et al., 2002) (all obtained from Sigma-Aldrich 189 
Chemical, Poole, UK) and 0.5% (v/v) QA Serum Protein Substitute. Embryos were 190 
cultured under Sage Oil at 37oC in 5% CO2 for 24 hours, alongside embryo-free 191 
control drops. Embryos were subsequently moved to fresh culture droplets and 192 
developmental observations made. Those embryos that had failed to form a 193 
blastocyst, but continued to undergo cell divisions/ organisation were classified as 194 
cleavage stage (cell number) or morula, whereas those that reached the blastocyst 195 
stage were classified according to their degree of expansion (unexpanded, 196 
expanded, hatched). An embryo that failed to develop after 48 hours culture was 197 
considered arrested.  Observations were ended on day 9. After incubation the spent 198 
culture medium was immediately frozen at -800C for later analysis. 199 
 200 
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Metabolic CORE profiles (Guerif et al., 2013) were determined by measuring the 201 
depletion and appearance of glucose, pyruvate, lactate and 18 amino acids, 202 
according to established techniques, that may be applied to individual oocytes and 203 
embryos:  204 
(i) Glucose and pyruvate consumption and lactate production were 205 
measured using ultramicrofluorometric assays described by Leese and 206 
Barton (1984) and modified by Guerif et al., (2013). The assays are based 207 
on the enzymic phosphorylation of substrate and the subsequent 208 
consumption or generation of NADH or NADPH in coupled reactions 209 
which causes an increase in fluorescence which could be measured using 210 
a plate reader (Tecan Infinite M200) (excitation 340nm, fluorescence 211 
459nm and above). All values are expressed as pmol embryo-1 hour-1.   212 
(ii) A coupled colorimetric assay was used to measure triglycerides as 213 
described by Sturmey and Leese (2003). Samples were pooled in groups 214 
of 2 to 5 embryos at equivalent development stages for each patient.  215 
(iii) Spent culture droplets were analysed for amino acids using reverse-216 
phase high performance liquid chromatography (HPLC), as described by 217 
Houghton et al., (2002). Average sums of amino acid production and 218 
depletion, were expressed in pmol embryo-1 hour-1 for day 5 to 9 of 219 
culture. All data were normalised to a non-metabolisable internal 220 
standard.  Results were recorded according to stage reached at the end 221 
of the period of culture 222 
 223 
Blastocyst cell counts  224 
Expanded blastocysts (n=44- see Figure 1B for details) were fixed on day 7 of 225 
development using the differential staining technique based on that described by 226 
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Thouas et al., (2001) for mouse and bovine blastocysts. Chromatin-specific dyes 227 
were used to determine ICM and TE counts. 228 
 229 
Statistical analysis 230 
The data were compared between normal and OW/OB women and correlated 231 
retrospectively to the study end points: (a) blastocyst development and (b) clinical 232 
pregnancy outcome of the sibling embryos form transferred sibling embryos (which 233 
had not been analysed).  Analyses were performed using SPSS, power calculations 234 
were performed based on the Birket and Day method (Birkett and Day, 1994), and 235 
studies were designed to achieve 80% power, unless otherwise stated. Leven’s test 236 
for normality was performed and ANOVA with Tukey Kramer as indicated. 237 
Univariate regression analysis was used to compare continuous data with paired t-238 
tests to compare grouped two sample data. ANOVA was used to assess intra- and 239 
inter-patient variability within the embryo cohort in combination with multiple linear 240 
regression analysis to determine the predictive accuracy of metabolic profile on 241 
blastocyst development rate.  To account for patient-specific effects in the triglyceride 242 
data, where samples where necessarily pooled into groups, Generalised Estimating 243 
Equations were used to separately model the mean response and within-cluster 244 
associations to reduce the variance and increase the power. Principal component 245 
analysis was used to reduce the dimensionality of the individual 18 amino acid 246 
measurements and adjust for multiple testing.  247 
248 
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Results 249 
In each of the experimental groups there were no significant differences in patient 250 
demographics; female age, AMH, male age and mean cycle number. However, 251 
follicle and oocyte numbers were significantly lower in the OW/OB groups compared 252 
to normal weight women in the observational study. In addition, male BMI was found 253 
to be elevated in partners of OW/OB women and has thus been controlled for 254 
appropriately, as described in the statistical methods. Similarly, intra-patient 255 
variability, which was evident for each cohort of oocytes / embryos has been taken in 256 
to consideration. 257 
 258 
We first compared oocyte diameter from overweight and obese women (BMI 259 
>25kg/m2) to women with a BMI <24.9kg/m2 (n=29 women, 218 oocytes in total) 260 
since oocyte diameter has been proposed as a marker of oocyte developmental 261 
competence (Wickramasinghe, et al., 1991). There were three key observations; 262 
women with a higher BMI had smaller oocytes (p<0.01, Figure 2A) more likely to be 263 
in the lower quartile range for diameter; smaller oocytes were less likely to complete 264 
cleavage after fertilisation (Fig 2B, r=0.23, p<0.001), and to form blastocysts (r=0.28, 265 
p<0.001). Intriguingly, despite higher rates of cleavage-stage arrest, embryos from 266 
oocytes from OW/OB women that were capable of reaching the morula stage did so 267 
17 hours earlier than counterparts from women with a BMI <25 (Figure 2C p<0.001). 268 
The resulting blastocysts from women with a BMI >25kg/m2 at equivalent time points, 269 
tended to be smaller (p=0.07) at the point of maximum expansion, and had 270 
significantly lower cell counts (Fig 3A). In a multivariate analysis of the expanded 271 
blastocyst data, only female BMI was shown to be a significant predictor of cell count 272 
(Fig 3B), independent of embryo diameter, female age, cause of infertility and male 273 
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BMI.  Furthermore, at equivalent time points, embryos from overweight and OW/OB 274 
mothers had fewer trophectoderm cells (p<0.001 (Fig 2B). 275 
 276 
We next sought to discover whether the metabolic activity of 37 human blastocysts 277 
from 7 overweight/obese women differed from that of 113 blastocysts collected from 278 
22 women who had a BMI <24.9. There were no other significant demographic 279 
differences between the groups including; age, cycle number and proportion IVF/ 280 
ICSI cycles as determined by independent sample t-test (Figure 1C), however male 281 
partners of OW/OB had significantly higher BMIs than those paired with normal 282 
weight women. We found that embryos from women with a BMI in excess of 25 283 
kg/m2 consumed significantly less glucose than embryos from women of a healthy 284 
weight at equivalent stages of development (p<0.001), whilst there were no 285 
significant changes in pyruvate uptake and lactate formation (Figure 4A). This pattern 286 
was consistent for each developmental stage. The reduced consumption of glucose 287 
occurred without a compensatory increase in pyruvate uptake, or of glycolytic activity 288 
as determined by lactate formation. In a multivariate analysis, developmental stage 289 
and female BMI were significant predictors of glucose uptake (p<0.05) and 290 
independent of male BMI, age, cause of infertility embryo grade and day each stage 291 
was attained. We were fortunate to identify a single male sperm donor that had been 292 
used to fertilise oocytes from 6 women, all of whom had a different BMI.  With the 293 
male factor was controlled in this way, we were able to confirm the results of the 294 
multivariate analysis, which suggested that differences in embryo glucose 295 
consumption were independent of male BMI (Figure 4B);  296 
Given these significant differences in glucose consumption, we compared the amino 297 
acid metabolism of embryos from overweight and obese women to those with a BMI 298 
<24.9 kg/m2. Increased overall amino acid turnover is indicative of poor embryo 299 
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quality in terms of implantation potential (Brison, et al., 2004) and DNA damage 300 
(Sturmey et al., 2009). Whilst we did not observe a significant difference in overall 301 
amino acid turnover, we did find that embryos from overweight women had striking 302 
differences in the consumption and release of individual amino acids compared to 303 
those from healthy weight women. Thus, the appearances in the culture medium of 304 
glutamate (p<0.01), aspartate (p<0.001), asparagine (p<0.01) and tryptophan 305 
(p<0.05) were elevated while the depletion of serine (p<0.01) and glutamine (p<0.01) 306 
were higher and that of isoleucine reduced in embryos from overweight group 307 
compared to normal weight women. When the analysis was restricted to 308 
developmental stage-matched blastocysts from the two BMI groupings the 309 
differences were less pronounced, however embryos from overweight  women still 310 
depleted significantly more methionine than embryos from normal weight  women 311 
(p<0.05 Figure 4C).  312 
 313 
Finally, we asked whether embryos from overweight women contained more 314 
triglyceride than counterparts from women with a BMI <24.9kg/m2. We observed that 315 
day 9 blastocysts from women with a BMI >25kg/m2 contained significantly more 316 
triglyceride than comparable embryos from women with a BMI<24.9kg/m2 (Fig 5A; 317 
p<0.001).  Moreover embryos that arrested contained significantly more triglyceride 318 
than those that completed development (11.32 ng vs 6.7 ng; p<0.001, Fig 5B). This 319 
apparent retention of triglyceride and reduction in glucose consumption most likely 320 
originates from the period of oocyte development, since all embryos were cultured in 321 
equivalent conditions in vitro. 322 
 323 
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In terms of pregnancy outcome, the CORE glucose, lactate and pyruvate values 324 
given by sibling non-transferred embryos did not correlate with patient pregnancy 325 
outcome, however considerable intra-patient variability was observed. This variability 326 
was reduced when the analysis was limited to only developing sibling embryos alone, 327 
however no significant correlation with pregnancy was evident. Similarly, the mean 328 
turnover of amino acids for all embryos from women achieving pregnancies, despite 329 
appearing to be lower, was not significantly different to the non-pregnant group 330 
(p=0.06). When the analysis was limited to a comparison with developing blastocysts 331 
only, significant differences were observed in the production of asparagine (p=0.02) 332 
and glutamine (p=0.04), which were lower in the pregnant group, similarly the uptake 333 
of arginine (p=0.03) was lower. With regards to triglyceride content, this tended to be 334 
lower (p=0.08) in the sibling embryos from women achieving a pregnancy compared 335 
to those whose treatment was not successful.   336 
 337 
338 
  17 
 
Discussion 339 
We report that embryos from overweight and obese women express a compromised 340 
developmental and metabolic phenotype. Specifically, oocytes from overweight and 341 
obese women are significantly smaller than those collected from women with a BMI 342 
considered to be in the healthy range.  These smaller oocytes from overweight and 343 
obese women are less likely to reach the blastocyst stage, but those that do so, 344 
show accelerated preimplantation development and the subsequent blastocysts 345 
contain fewer cells, notably in the trophectoderm.  These embryos also show 346 
significant metabolic abnormalities, with a diminished glucose consumption, altered 347 
profile of amino acid metabolism and strikingly, an increased endogenous triglyceride 348 
content.  The data provide strong evidence for a direct link between maternal 349 
nutrition, the periconceptual environment, oocyte and preimplantation developmental 350 
competence and embryo metabolism, which could have long-term health implications 351 
for the offspring.  352 
 353 
We found that oocytes collected from women with a BMI that exceeds 25 kg/m2 are 354 
significantly smaller than comparable oocytes collected from women whose BMI is 355 
less than 25 kg/m2; a finding in agreement with that of Marquard, et al., (2011). The 356 
impact of this observation is not yet clear, but Lucifero, et al., (2004) reported that the 357 
diameter of mouse oocytes was correlated with the accumulation of transcripts 358 
encoding for Dnmt3a, Dnmt3b and Dnmt3L; enzymes which play a critical role in the 359 
establishment and maintenance of DNA methylation.  Moreover, expression of one of 360 
these (DNMT3a) appears to be influenced by exposure of the oocyte to fatty acids 361 
(Van Hoeck, et al., 2011).  This may indicate that the smaller oocytes from OW/OB 362 
women, exposed to elevated levels of fatty acids in the follicle, have dysregulated 363 
expression of enzymes with an essential role in regulating methylation and 364 
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epigenetic control in the resulting embryo Furthermore, fewer oocytes from 365 
overweight and obese women were competent to reach the blastocyst once fertilised; 366 
a finding that may contribute to the lower success rates of fertility treatment that have 367 
been reported in overweight and obese women  (Bellver, et al., 2010, Chavarro, et 368 
al., 2012, Moragianni, et al., 2012, Shah, et al., 2011).    369 
 370 
Although fewer embryos from overweight and obese women reached the blastocyst, 371 
those that did so developed at a faster rate; an unexpected finding.  Specifically, 372 
embryos from overweight and obese women reached the morula stage of 373 
development on average 17 hours faster than comparable embryos from women of a 374 
healthy weight.  This precocious pre-compaction development meant that blastocysts 375 
were formed earlier in overweight and obese women, although the duration of 376 
cavitation once the morula stage had been reached did not differ.  The reasons 377 
behind this precocious development are unclear, particularly given the recent report 378 
by Bellver et al., (2013), who reported that embryos from overweight and obese 379 
patients had similar timings in cell division to embryos from women of normal weight.  380 
An important distinction between the work reported here and that of Bellver et al., 381 
(2013) relates the length of time that embryos were observed; Bellver et al., (2013) 382 
reported findings for 72 hours post fertilisation, although they did conceded that 383 
obesity may play an important role in the late stages of embryo development.  We 384 
now report for the first time that differences in developmental timing between 385 
embryos from OW/OB patients only became apparent after 68 hours post 386 
insemination.  387 
 388 
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We were surprised to find that the resulting blastocysts had fewer cells, notably in the 389 
trophectoderm lineage. The presence of fewer cells in the TE, from which the 390 
cytotrophoblast and syncitiotrophoblast will form, implies that at the time of 391 
implantation, there are fewer chorionic progenitor cells, which we propose may have 392 
an impact on the size and invasive properties of the trophoblast and subsequent 393 
placenta.  Disrupted cell allocation may have downstream effects on placental 394 
growth, which is likely to be important since both low and high placental weight at 395 
birth have been shown in epidemiological studies to predict the likelihood of 396 
developing coronary heart disease, hypertension, stroke and cancer in adulthood 397 
(Barker, et al., 1990, Eriksson, et al., 2011).  398 
 399 
In broad terms, the data on consumption of glucose by single human blastocysts are 400 
consistent with those previously reported (Gardner, et al., 2011, Hardy, et al., 1989).  401 
However, blastocysts from overweight and obese patients consumed significantly 402 
less glucose than equivalent embryos from women with a BMI <24.9 kg/m2.   A 403 
diminished capacity to metabolise glucose may be profound since there appears to 404 
be an evolutionarily conserved metabolic phenotype such that cleavage-stage 405 
embryos preferentially utilise pyruvate, while there is a characteristic increase in 406 
glucose consumption (Smith and Sturmey, 2013) during blastocyst formation.  A 407 
reduction of glucose consumption at the blastocyst stage suggests some degree of 408 
metabolic remodelling in the blastocysts derived from oocytes collected form 409 
overweight and obese women.  There are a number of reports that link embryo 410 
metabolism to ongoing developmental potential and Gardner et al., (2011) have 411 
proposed that low glucose consumption at the blastocyst stage relates to reduced 412 
human embryo viability. Given that in the current study, all of the embryos were 413 
cultured in equivalent conditions, we conclude that the origins of the altered glucose 414 
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metabolism in human blastocysts from overweight women can be traced back to 415 
conditions in the ovary.  In addition, we were fortunate in having a cohort of 6 416 
patients who received donor semen from a single donor, allowing us in essence to 417 
confirm the results from our statistical model which suggest that embryo metabolism 418 
is independent of male BMI. We observed a significant negative correlation between 419 
mean glucose consumption of blastocysts and female BMI, when the male 420 
contribution was controlled for, further supporting the conclusion that the origin of the 421 
metabolic alterations observed in the current study can be linked to the environment 422 
within the ovary.  However, there is good evidence that male obesity can also impact 423 
on fertility and embryo viability (Bakos, et al., 2011).  The molecular mechanism by 424 
which intra-follicular conditions modify the oocyte and subsequent embryo is unclear, 425 
but we consider it highly significant that bovine oocytes exposed to fatty acids at 426 
concentrations found in human ovarian follicles, (Robker, et al., 2009, Valckx, et al., 427 
2012) display reduced glucose consumption in the subsequent blastocysts (Van 428 
Hoeck et al 2011) as in our present study.    429 
 430 
The blastocysts of overweight and obese women consumed and produced a number 431 
of amino acids in increased quantities, compared to counterparts from women of a 432 
BMI <24.9 kg/m2, further pointing to a degree of metabolic regulation.  The increased 433 
appearance of aspartate and glutamate in embryos from OW/OB women might be 434 
indicative of a disrupted malate-aspartate shuttle (MAS), which plays a vital role in 435 
regulating glucose metabolism in mouse blastocysts (Mitchell, et al., 2009), and has 436 
a further function in regulating the REDOX status of the cytosol.  It is also noteworthy 437 
that inadequate metabolism of amino acids leads to a delay in trophectoderm 438 
development through an mTOR-dependent pathway (Martin and Sutherland, 2001).  439 
Given that we observed a reduction in TE cells in the embryos from overweight and 440 
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obese patients, and reduced amino acid metabolism, it is tempting to speculate that 441 
there is some degree of disruption to the mTOR signalling in these blastocysts.  In 442 
addition, embryos from overweight women consumed significantly more methionine 443 
which plays an important role in the metabolic regulation of nucleotide synthesis and 444 
methylation (Grillo and Colombatto, 2008); processes likely to be important up to the 445 
stage of blastocyst expansion which coincides with the end of DNA demethylation 446 
and loss of histone modifications and the onset of methylation (Feng, et al., 2010).   447 
 448 
This is the first quantitative report of triglyceride in human blastocysts, the total 449 
content of which was significantly lower than that observed in the domestic species 450 
(Ferguson and Leese, 1999, Sturmey and Leese, 2003, Sturmey, et al., 2009). Total 451 
endogenous triglyceride concentrations were lower in embryos that successfully 452 
develop to the blastocyst stage and that blastocysts derived from oocytes of 453 
overweight and obese patients contained significantly elevated levels of endogenous 454 
triglyceride. It is unlikely that de novo synthesis of fatty acid occurs in the embryo, 455 
although this cannot be discounted; more likely that oocytes present in the lipid-rich 456 
follicles of overweight and obese women accumulate triglyceride from the 457 
surrounding environment as reported by Aardema et al., (2011) and Ferguson and 458 
Leese, (1999) for domestic species.  This increased concentration of endogenous 459 
triglyceride is further evidence of metabolic remodelling in blastocysts derived form 460 
oocytes of overweight and obese women, and may explain the reduction in glucose 461 
consumption, since it is widely established in somatic cells and tissues that an 462 
increase in β-oxidation causes a reduction in glycolysis via elevated cytosolic citrate 463 
levels which inhibit phosphofructokinase (Hue and Taegtmeyer, 2009).   464 
 465 
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The data comparing metabolic parameters to the pregnancy outcome of the sibling 466 
transferred embryos highlights the differences in developmental potential apparent in 467 
a cohort of embryos; a potential weakness of using the woman as the ‘experimental 468 
unit’ as opposed to individual embryos. This assumes that the intra follicular 469 
conditions were comparable in the ovaries of a patient.  However in a given patient, 470 
even in follicles of comparable size, the degree of vascularization, oxygenation and 471 
level of nutrients have been shown to vary at the time of ovum retrieval (reviewed by 472 
Van Blerkom et al 2000).  The more subtle differences in metabolic regulation and 473 
developmental competence of individual embryos could be attributed to these 474 
differences and further studies are required on the origin of intra follicular influences. 475 
Studies on the consequences of maternal obesity have largely focussed on clinical 476 
complications for the mother during pregnancy and on offspring health; short- and 477 
long-term. Due to the complexities in working with human embryos and scarcity of 478 
material, much research on the impact of obesity on early development has been 479 
carried out in experimental animals (Van Hoeck, et al., 2011, Vogt, et al., 2014).  480 
Such data suggest that the early embryo is especially sensitive to nutritional and 481 
environmental challenges during the periconceptual period. Recent research efforts 482 
have begun to characterise the ‘re-programming’ that occurs at this time, and the 483 
consequences for future development. We believe that the work presented here is 484 
the first to examine the impact of maternal overweight or obesity on the development 485 
and nutrition of human oocytes and preimplantation embryos and shows that 486 
maternal metabolic health acts via the ovary to alter the phenotype of the oocyte.  487 
These alterations persist in the zygote and manifest, in our study as a disrupted 488 
metabolism at the blastocyst stage with the potential to compromise fetal and 489 
offspring health.   490 
 491 
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Figure Legends 649 
 650 
Figure 1 Schematic diagram of the study groups A-D, indicating patient numbers and 651 
demographics for each of the groupings (values are ± standard error). There were no 652 
difference in patient age and cycle number, significant differences in follicle and oocyte 653 
numbers in the observational study and male BMI in the CORE research grouping have been 654 
appropriately controlled for in the multivariate statistical analyses.  Shaded boxes indicate 655 
oocytes and embryos included within the analysis.  656 
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 657 
Figure 2 Developmental differences exist between oocytes generated from normal and 658 
Overweight & Obese (OW/OB) women. 2A) Oocyte diameter is inversely correlated to  659 
female BMI.  The data show mean (± SEM) oocyte diameters (n=218), recorded from 29 660 
women  (R2 =-0.45; p=0.001). 2B) The smallest oocytes, were significantly less likely to 661 
cleave (p<0.001) and more likely to have originated from women with a higher BMI (p<0.001; 662 
29 patients, n=155 embryos). 2C) The time elapsed post insemination for morula stage to be 663 
reached is shorter in embryos from OW/OB women compared to normal weight women 664 
(p<0.001, 25 patients, n= 101 supernumerary embryos taken for extended culture 665 
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observation).  As a consequence, post compaction stages of development arise earlier in 666 
embryos from OW/OB women, although the duration taken to complete blastocyst formation 667 
from the morula does not differ between OW/OB and normal weight women, suggesting 668 
precocious cleavage stage development. Note: discrepancies in numbers of embryos reflect 669 
exclusions from subsequent analysis due to fail-to fertilise oocytes (63 oocytes) and embryos 670 
transferred or cryopreserved as part of clinical treatment (54 embryos) – See Fig 1A for 671 
details. 672 
 673 
Figure 3; Total blastocyst cell counts, inner cell mass and trophectoderm cell counts for 674 
embryos that had been donated into research and had reached expanded blastocysts by day 675 
7 of development (n= 44; see Fib 1B for details).  3A) Shows that total, ICM and TE cell 676 
counts were significantly lower in blastocysts from OW/OB compared to normal weight 677 
women (p=0.01; mean values displayed). 3B) Shows the total, ICM and TE blastocyst cell 678 
counts, according to measures of total blastocyst diameter (µm) and ICM diameter (µm). 679 
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Blastocyst diameter shows a weak inverse relationship with female BMI (P=0.07). In a 680 
multivariate analysis diameter is not an independent predictor or cell count, whereas BMI is. 681 
The ICM count is predicted by female BMI and there is a trend for increased cell count with 682 
ICM diameter (p=0.08). The diameter of the ICM does not correlate with total cell count or 683 
total blastocyst diameter. 684 
 685 
Figure 4 Significant differences in the metabolism of embryos generated from normal and 686 
Overweight & Obese (OW/OB) women that had been donated into research (see Fig 1C for 687 
details). 4A) Embryos from women classified as OW/OB consume significantly less glucose 688 
than normal weight counterparts (p<0.001 37 embryos from 7 OW/OB women and 113 689 
embryos from 22 normal weight women. Error bars represent 95% CI). 4B) The glucose 690 
consumption of blastocysts is inversely correlated to female BMI (R2=-0.61; p=0.001) and 691 
relates to maternal BMI with little paternal influence The oocytes in this figure were all 692 
fertilised by the same sperm donor, yet reduced glucose consumption was apparent in 693 
embryos from OW/OB women.  (12 embryos from 3 women of a normal BMI and 13 embryos 694 
from 3 OW/OB women; See Fig 1D for details Data are expressed as mean ± SEM) 4C) 695 
Amino acid depletion (negative values) and appearance (positive values) by blastocysts of 696 
equivalent stage for OW/OB (n=20 blastocysts from 37 embryos total) and normal weight 697 
women (n=27 blastocysts from 113 embryos; see Fig 1C for details). There are no significant 698 
differences in the sum of uptake and production, however blastocysts from OW/OB women 699 
depleted significantly more methionine than embryos from women of healthy weight 700 
(p=0.037). Error bars represent 95% CI.   701 
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 702 
Figure 5: Triglyceride content of human embryos is influenced by maternal BMI.  5A) 703 
Embryos that had been donated into research (see Fig 1C for details) derived from oocytes 704 
collected from OW/OB women contain significantly more triglyceride than those from healthy 705 
weight women (t=4.11, **p<0.001). 5B) Embryos that arrest prior to the blastocyst stage 706 
(n=88) contain significantly more triglyceride than those capable of forming blastocysts (n=52; 707 
t=6.79, p<0.001), error bars represent standard error. Note, 10 embryos were unsuitable for 708 
analysis. This finding was consistent in both the normal weight and OW/OB women. Data are 709 
expressed as mean TG content ± SEM.    710 
